HLPpred-Fuse: improved and robust prediction of hemolytic peptide and its activity by fusing multiple feature representation.
Journal:
Bioinformatics (Oxford, England)
Published Date:
Jun 1, 2020
Abstract
MOTIVATION: Therapeutic peptides failing at clinical trials could be attributed to their toxicity profiles like hemolytic activity, which hamper further progress of peptides as drug candidates. The accurate prediction of hemolytic peptides (HLPs) and its activity from the given peptides is one of the challenging tasks in immunoinformatics, which is essential for drug development and basic research. Although there are a few computational methods that have been proposed for this aspect, none of them are able to identify HLPs and their activities simultaneously.